WO1993025176A1 - Freezing bags - Google Patents
Freezing bags Download PDFInfo
- Publication number
- WO1993025176A1 WO1993025176A1 PCT/GB1993/000975 GB9300975W WO9325176A1 WO 1993025176 A1 WO1993025176 A1 WO 1993025176A1 GB 9300975 W GB9300975 W GB 9300975W WO 9325176 A1 WO9325176 A1 WO 9325176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bag
- freezing
- outlet port
- cryoprotectant
- freezing bag
- Prior art date
Links
- 238000007710 freezing Methods 0.000 title claims abstract description 21
- 230000008014 freezing Effects 0.000 title claims abstract description 21
- 239000002577 cryoprotective agent Substances 0.000 claims abstract description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 206010018910 Haemolysis Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- -1 hydroxyethvl Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
Definitions
- the present invention relates to bags for use in the preservation of blood cells.
- Blood used for transfusion is normally stored in refrigerators, where its safe life is only five weeks. Potentially longer storage life might be obtained by freezing, but unfortunately freezing blood as obtained from a donor results in destruction of the red blood cells making the blood totally unsuitable for transfusions. Red blood cells can be stored after separation, by centrifuging, from the associated plasma, mixing with a cryoprotectant, and then freezing.
- the usual cryoprotectant is glycerol. As glycerol itself is poisonous frozen cells must have all the glycerol removed therefrom before being used for transfusion, and the necessary washing process is a skilled and time-consuming task which usually results in a significant loss of usable cells.
- HES hydroxyethvl starch
- the bags used in the method of PCT/GB90/0140 must be capable of fulfilling stringent criteria. Freezing is carried out in liquid nitrogen, and the manner in which the unavoidable changes in volume of the mixture of red blood cells and cryoprotectant during freezing are accommodated must be carefully controlled. It is also important that the concentration of HES is within stringent limits, and that the donation process is carried out in a sterile manner. It has been suggested that the HES be stored in the freezing bag itself. However it has been found that materials, suitable for the bag tend to be slightly porous, so that the moisture content of HES within a bag varies during storage, the nature of the variation being dependant on the atmospheric humidity of the store.
- bags which must, of course, be stored at sub-zero temperatures, should be of a convenient shape for storage, and that it should be possible to directly tap into a bag for transfusion purposes. Bags which fulfil this criterion are described in Patent Applications PCT/GB88/00947 and PCT/US91/00192.
- the manner of extraction from these involves penetration by a needle of the bottom fold of a pouch which extends inwardly of the bag. This procedure requires equipment which is not standard, and also requires new skills to be learnt by personnel giving transfusions.
- a freezing bag has an inlet port connected to an inlet tube to characterised in that the inlet tube is connected a cryoprotectant storage bag having an impervious cover, and an outlet port, the inlet tube and the outlet port each having a breakable seal.
- the impervious cover might be the actual material of the bag, or might be a separate cover surrounding the bag.
- the bag will normally be of generally rectangular, usually square, shape.
- the inlet port and outlet port will usually be on the same edge of the bag, with the outlet port preferably towards the centre of the edge, advantageously being slightly offset from the centre.
- Figure 1 is a view of a bag according to the invention.
- Figure 2 is a view, in section along line II-II of Figure 1, of a cryoprotectant storage bag.
- a freezing bag 10 ( Figure 1) suitable for use with the method of PCT/GB90/140 has, situated at one end of an edge 20, an inlet port 11 connected to a tube 12 having a breakable seal 13-
- a branch 14 from the tube 12 leads to a cryoprotectant storage bag 15 which is surrounded by a cover 16 (see Figure 2) made of impervious material.
- the cover 16 extends for a sufficient length of the branch 14 to insure that it will overlie any position to which cryoprotectant will penetrate.
- the outlet port 17 and seal 18 might conveniently be of the type used on conventional (non- frozen) storage bags.
- the cover 16 is removed from the cryoprotectant storage bag 15 and the breakable seal 13 removed from the tube 12, which is connected to a red blood cell supply (not shown) in known manner.
- Blood from a donor is centrifuged and the red cells therefrom passed through the tube 12 to the bag 10, cryoprotectant from the cryoprotectant storage bag 15 being passed through the branch 14 and tube 12 at the same time.
- the bag is then sealed, for example by thermally sealing along a line 19, in known fashion, and then removing the inlet port 11 and associated items.
- the bag 10 is then shaken to mix the red blood cells and cryoprotectant, frozen and stored according to the method of PCT/GB90/140.
- cryoprotectant storage bag 15 might be formed of impermeable material, there then being no need for a separate cover 16. However this arrangement makes it harder to protect cryoprotectant entering the branch 14.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
Abstract
A freezing bag (10) has an inlet port (11) connected to an inlet tube (12) having a breakable seal (13) and to which is connected a cryoprotectant storage bag (15) which is surrounded by an impervious cover (16), and an outlet port (17) having a breakable seal (18).
Description
FREEZING BAGS
The present invention relates to bags for use in the preservation of blood cells.
Blood used for transfusion is normally stored in refrigerators, where its safe life is only five weeks. Potentially longer storage life might be obtained by freezing, but unfortunately freezing blood as obtained from a donor results in destruction of the red blood cells making the blood totally unsuitable for transfusions. Red blood cells can be stored after separation, by centrifuging, from the associated plasma, mixing with a cryoprotectant, and then freezing. The usual cryoprotectant is glycerol. As glycerol itself is poisonous frozen cells must have all the glycerol removed therefrom before being used for transfusion, and the necessary washing process is a skilled and time-consuming task which usually results in a significant loss of usable cells. Another cryoprotectant is hydroxyethvl starch (HES) , which is non-toxic, and much work has been carried out on methods of preserving red blood cells using this substance. Early efforts were unsuccessful, as it was found that the level of haemolysis (breakdown of red blood cells) in units of blood (a unit of blood being the volume of a standard donation, about 450ml) recovered after freezing was above the safe limit. It is usually considered that to be safe for transfusion the level of haemolysis should be no greater the- 1% . A method of preserving and recovering red blood corpuscule Dy freezing, using HES as a cryoprotectant, wherein the level of haemolysis after recovery is within acceptable limits, has now been developed and is described in Patent Application PCT/GB90/0140.
The bags used in the method of PCT/GB90/0140 must be capable of fulfilling stringent criteria. Freezing is carried out in liquid nitrogen, and the manner in which the unavoidable changes in volume of the mixture of red blood cells and cryoprotectant during freezing are accommodated must be carefully controlled. It is also important that the concentration of HES is within stringent limits, and that the donation process is carried out in a sterile manner.
It has been suggested that the HES be stored in the freezing bag itself. However it has been found that materials, suitable for the bag tend to be slightly porous, so that the moisture content of HES within a bag varies during storage, the nature of the variation being dependant on the atmospheric humidity of the store.
It is also important that the bags, which must, of course, be stored at sub-zero temperatures, should be of a convenient shape for storage, and that it should be possible to directly tap into a bag for transfusion purposes. Bags which fulfil this criterion are described in Patent Applications PCT/GB88/00947 and PCT/US91/00192. The manner of extraction from these involves penetration by a needle of the bottom fold of a pouch which extends inwardly of the bag. This procedure requires equipment which is not standard, and also requires new skills to be learnt by personnel giving transfusions. According to the present invention a freezing bag has an inlet port connected to an inlet tube to characterised in that the inlet tube is connected a cryoprotectant storage bag having an impervious cover, and an outlet port, the inlet tube and the outlet port each having a breakable seal. The impervious cover might be the actual material of the bag, or might be a separate cover surrounding the bag.
The bag will normally be of generally rectangular, usually square, shape. The inlet port and outlet port will usually be on the same edge of the bag, with the outlet port preferably towards the centre of the edge, advantageously being slightly offset from the centre.
One embodiment of the invention will now be described, by way of example only, with reference to the accompanying diagrammatic drawings, of which: Figure 1 is a view of a bag according to the invention, and
Figure 2 is a view, in section along line II-II of Figure 1, of a cryoprotectant storage bag.
A freezing bag 10 (Figure 1) suitable for use with the method of PCT/GB90/140 has, situated at one end of an edge 20, an inlet port 11 connected to a tube 12 having a breakable seal 13- A branch 14 from the tube 12 leads to a cryoprotectant storage bag 15 which is surrounded by a cover 16 (see Figure 2) made of impervious material.
The cover 16 extends for a sufficient length of the branch 14 to insure that it will overlie any position to which cryoprotectant will penetrate.
At approximately the centre, but slightly offset from the centre, of the edge 20 is an outlet port 17 having a breakable seal
18. The outlet port 17 and seal 18 might conveniently be of the type used on conventional (non- frozen) storage bags.
In use the cover 16 is removed from the cryoprotectant storage bag 15 and the breakable seal 13 removed from the tube 12, which is connected to a red blood cell supply (not shown) in known manner.
Blood from a donor is centrifuged and the red cells therefrom passed through the tube 12 to the bag 10, cryoprotectant from the cryoprotectant storage bag 15 being passed through the branch 14 and tube 12 at the same time. The bag is then sealed, for example by thermally sealing along a line 19, in known fashion, and then removing the inlet port 11 and associated items. The bag 10 is then shaken to mix the red blood cells and cryoprotectant, frozen and stored according to the method of PCT/GB90/140.
When it is required to use the stored blood it is defrozen according to the method of PCT/GB90/140, the breakable seal 18 removed, and the outlet port 17 connected to transfusion means in the standard way.
It will be realised that with the outlet port 17 offset from the centre of the edge 20 a number of bags 10 may be stored in "back to back" fashion, such that adjacent ports 17 do not overlie, reducing the storage space required for a number of bags.
Many variations of the invention will be apparent to those skilled in the art. For example the cryoprotectant storage bag 15 might be formed of impermeable material, there then being no need for a separate cover 16. However this arrangement makes it harder to protect cryoprotectant entering the branch 14.
Materials suitable for use with the bag 10 and other items will readily be apparent to those skilled in the art. For example, many plastic materials having the required flexibility and suitability for use at low temperatures, are available commercially, and metallised plastics material may also be used.
Claims
1. A freezing bag (10) having an inlet port (11) connected to an inlet tube (12) characterised in that the inlet tube (12) is connected to a cryoprotectant storage bag (15) having an impervious cover (16), and an outlet port (17). the inlet tube (12) and the outlet port (17) each having a breakable seal (13. 18) .
2. A freezing bag as claimed in Claim 1 characterised in that the impervious cover (16) is separate from the storage bag (15).
3. A freezing bag as claimed in Claim 1 or in Claim 2 characterised in that it is of generally rectangular shape.
4. A freezing bag as claimed in Claim 3 characterised in that it is of generally square shape.
5. A freezing bag as claimed in any one of Claims 1 to 4 characterised in that the inlet port (11) and outlet port (17) are on a same edge (20) of the bag.
6. A freezing bag as claimed in any one of Claims 1 to 5 characterised in that the outlet port (17) is positioned towards the centre of an edge (20) of the bag.
7. A freezing bag as claimed in Claim 6 characterised in that the outlet port (17) is offset from the centre of the edge.
8. A freezing bag substantially as herein described with reference to Figures 1 and 2 of the accompanying drawings.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9400647A GB2272883B (en) | 1992-06-15 | 1993-05-12 | Freezing bags |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929212622A GB9212622D0 (en) | 1992-06-15 | 1992-06-15 | Freezing bags |
GB9212622.6 | 1992-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993025176A1 true WO1993025176A1 (en) | 1993-12-23 |
Family
ID=10717081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/000975 WO1993025176A1 (en) | 1992-06-15 | 1993-05-12 | Freezing bags |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB9212622D0 (en) |
WO (1) | WO1993025176A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006027565A1 (en) * | 2004-09-09 | 2006-03-16 | Lifeforce Group Plc | Apheresis tubing set |
WO2008035240A2 (en) * | 2006-07-19 | 2008-03-27 | Medical Mediterranea S.R.L. | Platelet freezing system |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0077189A1 (en) * | 1981-10-09 | 1983-04-20 | Biofusion (Proprietary) Limited | An infusion unit |
EP0253651A2 (en) * | 1986-07-16 | 1988-01-20 | Autologous Blood Corporation | Method for storing and processing blood |
WO1989004280A1 (en) * | 1987-11-04 | 1989-05-18 | Drg (Uk) Limited | Fluid containers and ports therefor |
WO1990005495A1 (en) * | 1988-11-15 | 1990-05-31 | Baxter International Inc. | Apparatus and method for collecting and freezing blood plasma |
WO1990009184A1 (en) * | 1989-02-08 | 1990-08-23 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | A method of freezing red blood cells |
-
1992
- 1992-06-15 GB GB929212622A patent/GB9212622D0/en active Pending
-
1993
- 1993-05-12 WO PCT/GB1993/000975 patent/WO1993025176A1/en active Application Filing
- 1993-05-12 GB GB9400647A patent/GB2272883B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0077189A1 (en) * | 1981-10-09 | 1983-04-20 | Biofusion (Proprietary) Limited | An infusion unit |
EP0253651A2 (en) * | 1986-07-16 | 1988-01-20 | Autologous Blood Corporation | Method for storing and processing blood |
WO1989004280A1 (en) * | 1987-11-04 | 1989-05-18 | Drg (Uk) Limited | Fluid containers and ports therefor |
WO1990005495A1 (en) * | 1988-11-15 | 1990-05-31 | Baxter International Inc. | Apparatus and method for collecting and freezing blood plasma |
WO1990009184A1 (en) * | 1989-02-08 | 1990-08-23 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | A method of freezing red blood cells |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006027565A1 (en) * | 2004-09-09 | 2006-03-16 | Lifeforce Group Plc | Apheresis tubing set |
WO2008035240A2 (en) * | 2006-07-19 | 2008-03-27 | Medical Mediterranea S.R.L. | Platelet freezing system |
WO2008035240A3 (en) * | 2006-07-19 | 2008-09-12 | Medical Mediterranea S R L | Platelet freezing system |
Also Published As
Publication number | Publication date |
---|---|
GB9400647D0 (en) | 1994-03-09 |
GB9212622D0 (en) | 1992-07-29 |
GB2272883A (en) | 1994-06-01 |
GB2272883B (en) | 1996-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4994021A (en) | Apparatus and method for collecting and freezing blood plasma | |
US3110308A (en) | Parenteral fluid administration equiment | |
US4131200A (en) | Thermoplastic blood bag | |
US3986506A (en) | Apparatus for separation of cryoprecipitate from blood plasma and method | |
EP0540732B1 (en) | Systems and methods for removing undesired matter from blood cells | |
US4198972A (en) | Blood and blood component storage bags | |
US5770051A (en) | Apparatus for separating blood in an integrally formed container | |
US4902287A (en) | Sterilizable system for blood storage | |
USRE27132E (en) | Apparatus for treating blood | |
US20080234653A1 (en) | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma | |
US4025618A (en) | Method for separation of cryoprecipitate from blook plasma | |
EP0233112A1 (en) | Method for separation of blood components and apparatus therefor | |
EP2868306B1 (en) | Method for sealing a multi-chamber freezing bag | |
US4508236A (en) | Container and associated cap assembly for plasma collection and the like | |
EP0728522B1 (en) | Blood collection assembly having additive dispensing means and method for sample collection using same | |
CN109152698B (en) | Plasma bottle without sealing piece and top cover thereof | |
WO1993025176A1 (en) | Freezing bags | |
AU674163B2 (en) | Freezing bags | |
IL47945A (en) | Method and apparatus for the separation of cryprecipitate separation of cryoprecipitate from blood plasma | |
JPS63132658A (en) | Blood preserving container | |
EP0420757B1 (en) | Multiple blood bag system | |
EP0720468B1 (en) | Freezing frames for blood bags | |
EP2982374A1 (en) | Red blood cell storage solution, storage solution accommodating container, manufacturing method for red blood cell storage solution, and red blood cell bag system | |
US20060167401A1 (en) | Apparatus and method for stem cell preservation and usage | |
JPH02152455A (en) | Container and method for preserving platelet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA GB US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |